Your browser doesn't support javascript.
loading
Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan.
Kagawa, Y; Shinozaki, E; Okude, R; Tone, T; Kunitomi, Y; Nakashima, M.
Affiliation
  • Kagawa Y; Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka.
  • Shinozaki E; Gastroenterology Center, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo.
  • Okude R; Medical Affairs Department, Taiho Pharmaceutical Co., Ltd., Tokyo.
  • Tone T; Medical Affairs Department, Taiho Pharmaceutical Co., Ltd., Tokyo.
  • Kunitomi Y; Data Science Department, Taiho Pharmaceutical Co., Ltd., Tokyo.
  • Nakashima M; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Electronic address: nakashima.masayuki.36a@st.kyoto-u.ac.jp.
ESMO Open ; 8(4): 101614, 2023 08.
Article in En | MEDLINE | ID: mdl-37562196
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Colonic Neoplasms / Frontotemporal Dementia Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: ESMO Open Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Colonic Neoplasms / Frontotemporal Dementia Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: ESMO Open Year: 2023 Document type: Article